Mylan Gets ANDA Approval For Generic Of J&J’s Topamax

Mylan unlikely to launch until 2008 unless successful on patent litigation.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet